Loading...
Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemia
The treatment of older patients with acute myeloid leukemia that is secondary to previous myelodysplastic syndrome, myeloproliferative neoplasm, or prior cytotoxic exposure remains unsatisfactory. We compared 92 and 107 patients treated, respectively, with intensive chemotherapy or azacitidine withi...
Saved in:
Published in: | Oncotarget |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Impact Journals LLC
2017
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5668025/ https://ncbi.nlm.nih.gov/pubmed/29108292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15988 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|